Fact CheckerSign in

NCT07404943Completed

The Effect of Telenursing on Functionality and Treatment Adherence in Bipolar Disorder

The Effect of Telenursing Counseling on Functioning and Treatment Adherence Levels in Individuals With Bipolar Disorder

Source: ClinicalTrials.gov · Last updated 31 Jul 2026

Brief summary (registry, in English)

This research is a randomized controlled experimental study with a pretest-posttest design, conducted to determine the effect of telenursing counseling on functionality and treatment adherence levels in patients with bipolar disorder. First, patients followed up with a diagnosis of bipolar disorder at the Community Mental Health Center (CMHC) were evaluated by the researcher through face-to-face interviews in terms of the inclusion criteria. Patients who met the criteria and voluntarily agreed to participate in the study were informed about the research, and their written informed consent was obtained. Subsequently, the participants were assigned to the experimental and control groups by an independent faculty member using a stratified block randomization method. Following the randomization process, a nurse working at the Community Mental Health Center administered the Descriptive Information Form, the Short Functioning Assessment Scale, and the Morisky Medication Adherence Scale to both groups face-to-face as a pretest. After the baseline measurements, an eight-week telenursing counseling intervention was implemented with the patients in the experimental group. No intervention was provided to the control group; they only received standard treatment and care services. At the end of the eight-week period, the same nurse working at the CMHC administered the SFAS and MMAS scales again, and the posttest measurements were obtained.

Status (registry)
Completed
Study type
Interventional
Enrollment
70 (actual)
First submitted
24 Jan 2026
Start date
1 Dec 2024
Primary completion date
1 Sept 2025
Lead sponsor
Didem Ayhan
NCT number
NCT07404943

What you commit to

  • Study type: Interventional
  • Participants enrolled: 70
  • From 1 Dec 2024 to the primary completion date, 1 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Concurrent participation in another psychoeducation or tele-intervention program with similar content.

Other illness

  • Presence of a comorbid mental disorder (e.g., severe personality disorder, substance use disorder),
  • Being unable to continue tele-intervention due to a serious physical illness (e.g., cancer, heart failure) and/or cognitive impairment (e.g., loss of intellectual capacity, neurocognitive disorder),
  • Presence of conditions that make tele-access impossible,

Other

  • Presence of an acute mood episode,

Who the study is looking for

  • Having received a diagnosis of bipolar disorder (Type I/II) at least one year ago according to the diagnostic criteria specified in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR),
  • Being followed up at the Community Mental Health Center (CMHC) for at least one year,
  • Having a Morisky Medication Adherence Scale score of ≥ 1,
  • Having at least a primary school education,
  • Owning a mobile phone and having no visual and/or hearing impairment related to calling/messaging use,
  • Voluntarily agreeing to participate in the research.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kütahya Evliya Çelebi Training and Research Hospital
Coordinator of this site? Confirm its status
KütahyaTurkey (Türkiye)Unknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.